From its peak, $MET-3.3% shares have quickly fallen below the TOP values of the years before the 2008 crisis.

This stock is -21% this year despite the market. It has bounced off the $50 level - there was support from 2019 before the big fall came.

Recent earnings have not been good and the company's profitability is plummeting.
MetLife provides financial services and is in the insurance business. Buying the stock?

MET

MetLife

MET
$74.08 -$2.50 -3.26%

A quick glance: the debt is alarming. Cash flow, total cash, and high payout ratios don't help. I don't know if the dividend is sustainable over the long term. The multiples look good.

I shopped this company in covid and so far I'm still holding. It's a long term investment.

Don't have an account? Join us

Log in to Bulios


Sign.popup.orUseEmailAndPassword
Už jsi členem? Přihlásit se

Create Bulios profile

Continue with

Sign.popup.orUseEmailAndPassword
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data and information on thousands of stocks from around the world

Current information from global markets and individual companies

sign.popup.registration.listWhy.fourth

Fair prices, portfolio tracker, stock screener and other tools

Timeline Tracker Overview